The landscape of dementia diagnosis has evolved significantly with the advent of advanced biomarkers, which includes amyloid PET scans, tau imaging, and blood-primarily based tests that can detect Alzheimer's pathology decades before signs arise. When these technological improvements signify extraordinary progress in understanding neurodegenerative health conditions, they may have not https://stanleyz964tcl3.bloggip.com/profile